Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

HMGN1 Antikörper

Der Maus Monoklonal Anti-HMGN1-Antikörper wurde für WB, IHC und ELISA validiert. Er ist geeignet, HMGN1 in Proben von Human zu detektieren.
Rockland
Produktnummer ABIN103313
Hersteller Produkt- Nr.: 200-301-278

Kurzübersicht für HMGN1 Antikörper (ABIN103313)

Target

Alle HMGN1 Antikörper anzeigen
HMGN1 (High Mobility Group Nucleosome Binding Domain 1 (HMGN1))

Reaktivität

  • 64
  • 19
  • 14
  • 6
  • 6
  • 5
  • 5
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Human

Wirt

  • 65
  • 2
Maus

Klonalität

  • 65
  • 2
Monoklonal

Konjugat

  • 33
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
Dieser HMGN1 Antikörper ist unkonjugiert

Applikation

  • 44
  • 28
  • 26
  • 24
  • 24
  • 15
  • 10
  • 8
  • 7
  • 5
  • 2
  • 2
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC), ELISA

Klon

IPO-38
  • Hersteller Produkt- Nr.

    200-301-278

    Hersteller

    Rockland

    Verwendungszweck

    IPO-38 Antibody

    Kreuzreaktivität (Details)

    This antigen was detected after 12h of PHA-induced activation in the early G1 phase but absent in non-stimulated lymphocytes.

    Produktmerkmale

    Synonyms: mouse anti-IPO38 antibody, mouse anti-HMGN1 antibody, mouse anti-HMG14 antibody, Non-histone chromosomal protein HMG-14 antibody, High-mobility group nucleosome-binding domain-containing protein 1 antibody

    Aufreinigung

    Anti-IPO-38 monoclonal antibody was purified by Protein A chromatography.

    Sterilität

    Sterile filtered

    Immunogen

    Immunogen: A BALB/c mouse was immunized with spleen cells of a human patient with hairy cell leukemia.

    Immunogen Type: Native Protein

    Isotyp

    IgM kappa
  • Applikationshinweise

    Immunohistochemistry Dilution: 10 μg/mL

    Application Note: Anti-IPO-38 has been tested by immunohistochemistry (frozen and formalin/paraffin) and western blot analysis on the Raji cell line and reacts with a 14 -16 kDa protein. This antibody is suitable for ELISA and immunoprecipitation.  The antibody is reported to recognize a nuclear antigen that is present in the cytoplasm and nuclei of proliferating cells (paraformaldehyde fixed, Triton X-100 permeabilized).  An increase of 400 % is observed in cells in mitosis (determined by analysis of K562 cells synchronized with colcemid).  IPO-38 does not block the binding of the Ki-67 antibody.   Tonsillar tissue is typically used as a positive control.

    Western Blot Dilution: 1:500- 1:2,000

    ELISA Dilution: 1:10,000 - 1:50,000

    Other: User Optimized

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Konzentration

    1.0 mg/mL

    Buffer

    Buffer: 0.02 M Potassium Phosphate, 0.5 M Sodium Chloride, pH 7.2

    Stabilizer: None

    Preservative: 0.01 % (w/v) Sodium Azide

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C,-20 °C

    Informationen zur Lagerung

    Store vial at -20° C prior to opening. Aliquot contents and freeze at -20° C or below for extended storage. Avoid cycles of freezing and thawing. Centrifuge product if not completely clear after standing at room temperature. This product is stable for several weeks at 4° C as an undiluted liquid. Dilute only prior to immediate use.

    Haltbarkeit

    12 months
  • Target

    HMGN1 (High Mobility Group Nucleosome Binding Domain 1 (HMGN1))

    Andere Bezeichnung

    Hmgn1

    Hintergrund

    Background: The specificity of mAb IPO-38 was demonstrated in different human and murine lymphoid and non-lymphoid cell lines. It does not react with mononuclear cells and granulocytes of healthy donors but does react with nuclei of blood cells of patients with different forms of leukemia and with cells from lymph nodes of patients with Hodgkin's disease and non-hodgkin's lymphoma. Also a positive reaction in nuclei of breast and colorectal tumor cells was demonstrated. IPO-38 may be a good marker of cellular proliferation during monitoring of tumor progression.

    Gen-ID

    15312

    NCBI Accession

    NP_032277

    UniProt

    P18608

    Pathways

    Chromatin Binding
Sie sind hier:
Chat with us!